Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Numinus Wellness Inc T.NUMI

Alternate Symbol(s):  NUMIF

Numinus Wellness Inc. is a Canada-based mental health care company. The Company helps people to heal and be well through the development and delivery of mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Company's segments include Clinical Research Operations, Canadian Clinic Network and US Clinic Network. Its Clinical Research Operations is focused on licensed psychedelic research and provides clinical research management services to academic institutions and biotechnology companies. Its Canadian Clinic Network segment includes wellness clinics based in Canada offering clinical services, including traditional therapy and counseling, ketamine-assisted therapies, mindfulness programs, and virtual psychotherapy. The US Clinic Network segment includes wellness clinics based in the United States that offers clinical services, such as psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management.


TSX:NUMI - Post by User

Comment by 02Gliderideron Jan 22, 2021 9:45am
314 Views
Post# 32358276

RE:RE:Horizons ETF PSYK List

RE:RE:Horizons ETF PSYK List

Horizon's Psychedelic ETF (PSYK) is expected to commence trading Jan. 26, 2021 and includes 17 psychedelic companies in the first ever Psychedelic ETF

Will trade on the Canadian NEO Exchange under the ticker PSYK. The ETF includes companies in the Canadian legal psychedelics industry, as well as U.S. companies engaged in legal activities involving psychedelic drugs and substances. The purpose of the ETF is to "invest in, and indirectly derive revenues from, companies in the psychedelics industry engaged in legal activities involving psychedelic drugs and substances."

MER = 0.85%

The ETF will include:

  • Johnson & Johnson (JNJ)

  • AbbVie Inc (ABBV)

  • COMPASS Pathways (CMPS)

  • Field Trip Health (FTRP)

  • MindMed (MMED)

  • Greenbrook TMS Inc (GTMS)

  • Entheon Biomedical (ENBI)

  • Seelos Therapeutics (SEEL)

  • Cybin (CYBN)

  • Mind Cure Health (MCUR)

  • Havn Life Sciences (HAVN)

  • Numinus (NUMI)

  • Mydecine Innovations (MYCO)

  • Nova Mentis (NOVA)

  • Psyched Wellness (PSYC)

  • Revive Therapeutics (RVV)

  • Red Light Holland (TRIP)


<< Previous
Bullboard Posts
Next >>